News
Zacks Investment Research on MSN6h
Tesla Losing Steam in Europe: What's Impeding Its Growth?Tesla’s TSLA car sales dropped significantly in several European countries in May, which marks the fifth straight month of ...
Bloomberg recently reported that Tesla will launch its first robotaxis in Austin on June 12. The launch marks what could be ...
Elon Musk's decision to cancel the planned low-cost $25,000 EV, known as Model 2, has left Tesla executives divided. This ...
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.
The Cool Down on MSN19h
Tesla driver shares chilling footage of Full Self-Driving failure during routine trip: 'There's absolutely nothing you could've done'A Tesla driver shared disturbing dashcam footage that may give consumers pause about trusting the electric vehicle automaker ...
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback